Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy Cantor Fitzgerald

Start price
€11.30
04.04.24 / 50%
Target price
-
04.04.25
Performance (%)
-4.42%
Price
€11.40
08:55
Summary
This prediction is currently active. With a performance of -4.42%, the BUY prediction for Stoke Therapeutics Inc by Cantor_Fitzgerald is down slightly. This prediction currently runs until 04.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w
Stoke Therapeutics Inc -3.636%
iShares Core DAX® 2.594%
iShares Nasdaq 100 3.553%
iShares Nikkei 225® 0.687%
iShares S&P 500 2.209%

Comments by Cantor_Fitzgerald for this prediction

In the thread Stoke Therapeutics Inc diskutieren

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for STOK provided by MarketBeat